[1]
Meriyani, H., Sanjaya, D.A., Juanita, R.A., Siada, N.B. and Chusna, N. 2025. Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review. Borneo Journal of Pharmacy. 8, 1 (Feb. 2025), 33–48. DOI:https://doi.org/10.33084/bjop.v8i1.7913.